Keosys-Blog-Graphic-1

The Keosys Blog

Expert insights into medical imaging in clinical trials.

Recent

Keosys
Interview: 2022 in Review with Oana Popa-Nita
2022 Year in Review 2022 is coming to a close, and it’s a great time to reflect..
Keosys
The Best Keosys Blogs of 2022
Recap: Top blog posts of 2022 It’s been a great year for Keosys, the..
Keosys
Why are so many imaging queries sent to your site and how can you avoid them?
Why are so many imaging queries sent to your site and how can you avoid them?..
Case Study - Setting up a Project in a Short Turnaround Time
Sometimes sponsors and CROs are not sure in the early stages of a trial that..
Automatic Segmentation of Metastatic Breast Cancer Lesions on F-FDG PET/CT Longitudinal Acquisitions for Treatment Response Assessment
Introduction Metastatic breast cancer patients receive lifelong medication and..
Modified Recist for HCC with Infographic
mRECIST was developed in 2010 to adapt RECIST v1.1 to the particularities of..
Questions to Ask Yourself About Imaging in Clinical Trials
Starting a trial can be very challenging. There are many actors involved and..
5 Myths About Imaging CROs
In the race against COVID, clinical trials regularly made the headlines. People..
Automatic Quantification of Background Activity in the PERCIST Criteria
Positron Emission tomography Response Criteria In Solid Tumors (PERCIST) allows..
Photography as Imaging in Dermato-Oncology Clinical Trials
The health industry has been impacted by numerous technological advances in..
Case Study - Rescuing a Complicated Trial
Complex trials with multiple efficacy endpoints or multiple imaging modalities..
Keosys
Central Review According to iRECIST in Cancer Immunotherapy Clinical Trials
This is an excerpt from our free eBook “Imaging and Read Criteria in Cancer..
All posts

More Posts

New call-to-action

Information

Europe

13 Impasse Serge Reggiani
44800 Saint-Herblain
FRANCE

Phone: +33 2 53 59 12 90

North America

55 Fifth Avenue Suite 1807
New York, NY 10003 
USA

Phone: +1 646 797 2724